Skip to contentSkip to filters

We use cookies for analytics.

Grant

Improving Quality of Care and Scalable Implementation of Bispecific Antibody Therapy in Multiple Myeloma

Pfizer

  • Germany
  • Institution applies
  • Oncology, Hematology and
Related content

About

Quality improvement projects can test how German oncology teams deliver BCMA-targeting bispecific antibodies for multiple myeloma. Priorities include outpatient care, safer monitoring, multidisciplinary coordination and support for patients and caregivers.

Topics

Eligibility

Covers: Up to EUR 100,000 for projects of up to 24 months.

The geographic scope of the call is DE.

cdn.pfizer.compfizer.com

German healthcare institutions, professional schools and societies, government agencies and other organizations with a healthcare improvement mission can apply.

Source: cdn.pfizer.com